During the past decade, Kelsey Research Foundation conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kelsey Research Foundation" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "Pfizer" with 3 trials sponsored, "University of Washington" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Axio Research. LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kelsey Research Foundation" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kelsey Research Foundation" are "Hepatitis C, Chronic" (5 trials), "Atherosclerosis" (3 trials), "Cardiovascular Diseases" (2 trials), "Coronary Disease" (2 trials) and "Heart Diseases" (2 trials). Many other conditions were trialed in "Kelsey Research Foundation" in a lesser frequency.

Most popular intervention types in "Kelsey Research Foundation" are "Drug" (11 trials), "Biological" (3 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Simvastatin" (2 trials), "TDF" (2 trials), "Clostridium difficile vaccine" (1 trials), "Copegus®" (1 trials) and "Extended release niacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kelsey Research Foundation" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kelsey Research Foundation". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Kelsey Research Foundation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kelsey Research Foundation, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".